Simplified Chinese
Conducting field visits and surveys to gain a clear understanding of the situation, soliciting enterprises’ needs to promote development—Shi Yinfeng, Deputy Secretary of the Daxing District Party Committee, paid a visit to Minhai for research and guidance.
Release date:
2022-07-12
Author:
Source:
Abstract
On the afternoon of July 6, 2022, Shi Yinfeng, Deputy Secretary of the Daxing District Party Committee, accompanied by Ma Yanzhu from the District Industrial Promotion Center and Zhang Long, General Manager of the Biopharmaceutical Base Company, paid a visit to Minhai Bio for research and guidance. The company’s General Manager Zheng Haifa, Executive Deputy General Manager Liu Jiankai, Production Deputy General Manager Nie Xiaoqi, and other relevant leaders were present to receive the delegation.

At the research meeting, Company President Zheng first extended a warm welcome on behalf of the company’s leadership to Secretary Shi and his delegation. He then briefed the leaders on the company’s development journey, its major achievements over the past few years, its future development plans and strategic positioning, and placed particular emphasis on the progress of planning and construction for the new international‑standard vaccine industrial base. Secretary Shi expressed full appreciation for Minhai Bio’s development and encouraged the company to leverage its product portfolio to continue contributing to the pharmaceutical industry. He also inquired about the challenges encountered during the construction of the new international‑standard vaccine industrial base and pledged to coordinate with relevant departments after the meeting to provide support and assistance.

Following the conclusion of the symposium, Zheng Haifa, General Manager of the company, stated that Minhai Bio’s achievements have been made possible thanks to the strong support and favorable conditions provided over the years by the Daxing District Government and the Biomedical Base. He added that, moving forward, the company will continue to innovate, strengthen its core competitiveness, and translate its corporate culture—“Creating Better Vaccines to Serve Human Health”—and its ambitious vision into concrete actions, thereby contributing to the development of the biomedical industry in Daxing District.
Keywords:
Recommended Reading
Batch Release Status of the Company’s Products in 2026
2026-07-23
2026-07-15
2026-07-09